Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213)

Category Primary study
JournalCardio-Oncol.
Year 2025
This article has no abstract
Epistemonikos ID: 495a1a9a463b2e450a55bb1486ceb881c9b4be1d
First added on: Mar 07, 2025